Imidazole → HCID 12150196, compound
Reaction equation
[H-].[Na+].[NH:3]1[CH:7]=[CH:6][N:5]=[CH:4]1.Cl[CH2:9][CH2:10][C:11]1[N:20]=[C:19]([C:21]2[CH:26]=[CH:25][C:24]3[O:27][CH2:28][O:29][C:23]=3[CH:22]=2)[C:18]2[C:13](=[CH:14][C:15]3[O:32][CH2:31][O:30][C:16]=3[CH:17]=2)[N:12]=1.[Na+].[I-]>CN(C=O)C.CCCCCC>[N:3]1([CH2:9][CH2:10][C:11]2[N:20]=[C:19]([C:21]3[CH:26]=[CH:25][C:24]4[O:27][CH2:28][O:29][C:23]=4[CH:22]=3)[C:18]3[C:13](=[CH:14][C:15]4[O:32][CH2:31][O:30][C:16]=4[CH:17]=3)[N:12]=2)[CH:7]=[CH:6][N:5]=[CH:4]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To a suspension of hexane washed NaH (60% in oil, 84 mg, 2.1 mmol) in dry DMF (5 mL) was added imidazole (142 mg, 2.1 mmol). The mixture was stirred at rt for 15 min and was treated with 2-chloroethyl-6,7-methylenedioxy-4-(3,4-methylenedioxyphenyl)quinazoline (232 mg, 0.7 mmol), and then with NaI (105 mg, 0.7 mmol). The mixture was stirred at rt for 15 h and it was poured into ice-water. The precipitated solid was collected by filtration, washed with water, and air dried. The yellow solid was then crystallized from EtOAc to give the title compound as pale yellow needles (101 mg); mp 160-163° C.; 1H NMR (CDCl3) 7.5 (s, 1H) 7.33 (s, 1H), 7.27 (s, 1H), 7.15-7.20 (m, 2H), 6.91-7.05 (m, 3H), 6.15 (s, 2H), 6.08 (s, 2H), 4.60 (m, 211), 3,53 (m, 2H). Anal. calcd. for C21H16N4O4: C, 64.94; H, 4.15; N, 14.43. Found: C, 64.52; H, 4.11; N, 14.12.
Workup
- stirringThe mixture was stirred at rt for 15 h
- filtrationThe precipitated solid was collected by filtration
- washwashed with water, and air
- customdried
- customThe yellow solid was then crystallized from EtOAc
Sources & evidence
- ORD record
- ord-2ace5ba929b041759e947e4d4dba2afc
- Source dataset
- uspto-grants-2004_07
- Patent number
- US06765006B2
Reaction notes
Loading…